weight loss on .25 semaglutide 🚨 Oral 25 mg delivers double-digit in OASIS-4 (Phase 3 trial) - Retatrutide for weight loss: Study

However, in 2021, the FDA approved semaglutide, the same active drug in Ozempic, under the brand name Wegovy as a weight loss medication

This has raised concerns among doctors that patients with diabetes, who rely on the medication for blood sugar control, may face difficulties accessing their prescriptions

This weakened response to GLP-1 can make it challenging to manage blood sugar levels in patients with diabetes and may require alternative treatment methods or adjustments in medication dosage. Medication interference People taking a GLP-1 drug with other medications may see less weight loss

More importantly, because MB can cause oxidative stress and has a potential for genotoxicity, there is a concern for the nursing infant